FORESITE CAPITAL MANAGEMENT IV, LLC – Lyell Immunopharma, Inc. Transaction History
FORESITE CAPITAL MANAGEMENT IV, LLC portfolio value:
$73.3M
portfolio value
FORESITE CAPITAL MANAGEMENT IV, LLC quarter portfolio value change:
+12.42%
quarter
Lyell Immunopharma, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -24.71% | -3.28M shares | -13.3M | $7.33 | 10M |
| Q2 2022 | share | 0.00% | 0 shares | 19.52M | $6.52 | 13.28M | |
| Q1 2022 | share | 0.00% | 0 shares | -35.72M | $5.05 | 13.28M | |
| Q4 2021 | share | 0.00% | 0 shares | -93.77M | $7.55 | 13.28M | |
| Q3 2021 | share | 0.00% | 0 shares | -19.12M | $14.8 | 13.28M | |
| Q2 2021 | share | Increase | 0.00% | 13.28M shares | 215.70M | $16.24 | 13.28M |